Ignite Creation Date:
2025-12-26 @ 10:56 AM
Ignite Modification Date:
2025-12-29 @ 12:22 PM
Study NCT ID:
NCT00720408
Status:
COMPLETED
Last Update Posted:
2009-09-15
First Post:
2008-07-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.
Sponsor:
Astellas Pharma Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PRGXLLTx-0702-TW
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Director
Old Organization:
Astellas Pharma Inc.
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |